Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis in the Arctic.

Brian J McMahon1

  • 1Viral Hepatitis Program, Alaska Native Medical Center Anchorage, Alaska 99508, USA. bdm9@cdc.gov

International Journal of Circumpolar Health
|March 2, 2005
PubMed
Summary

Viral hepatitis A, B, C, and D are prevalent in Arctic indigenous populations. Vaccination and antiviral therapies offer effective prevention and treatment strategies for these viral infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thirty years of hepatitis A epidemiology and vaccine studies: A narrative review of lessons learned in Alaska.

Annals of epidemiology·2026
Same author

Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B?

Expert review of anticancer therapy·2026
Same author

Elimination of Hepatitis B virus transmission in an endemic area in Western Alaska.

IJID regions·2025
Same author

Modeling 5-Year Hepatocellular Carcinoma Risk in Alaska Native Peoples With Hepatitis B Virus Infection.

Gastro hep advances·2025
Same author

HCC surveillance in hepatitis C: A longitudinal algorithm improves alpha-fetoprotein screening.

Hepatology communications·2025
Same author

Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project Following 2015 WHO Treatment Guidelines, 2017-2021.

Journal of viral hepatitis·2024

Area of Science:

  • Arctic health research
  • Viral hepatitis epidemiology
  • Indigenous population health

Background:

  • Viral hepatitis poses a significant health burden in Arctic indigenous communities.
  • Understanding the prevalence and impact of hepatitis A, B, C, and D is crucial for public health interventions.

Purpose of the Study:

  • To synthesize existing research on viral hepatitis in Arctic indigenous populations.
  • To identify prevalence rates, transmission patterns, and effective control measures.

Main Methods:

  • Comprehensive literature review of studies published between 1966 and 2003.
  • Medline database search to identify relevant research articles.

Main Results:

  • High seroprevalence of hepatitis A (over 50%) and hepatitis B (22-42% total infection) reported.
  • Significant rates of chronic hepatitis B infection (3-12%) identified across Arctic regions.
  • Hepatitis C prevalence is below 1.4%, while hepatitis D co-infection with hepatitis B reaches 40% in Greenland.

Conclusions:

  • Viral hepatitis A, B, C, and D are endemic in the Arctic, affecting indigenous populations disproportionately.
  • Vaccines for hepatitis A, B, and D are effective in preventing transmission.
  • Antiviral therapies show promise for treating chronic hepatitis B and C infections.

Related Experiment Videos